Arena (ARNA) garners positive Advisory Committee vote

A couple of years after it should have occurred, but ARNA got a 18-4-1(abstain) thumbs up from the FDA's Advisory Committee today. The company's weight-loss drug Lorquess is up for approval. The stock nearly doubled to $6.85 after opening for trading in after hours - it was halted during the Committee meeting and vote. The actual approval decision is not due until June, but expect fireworks over the next couple days. Congratulations to the longs (of which I happen to be a member in my personal accounts) and to the company. Regards, Trond This site is for educational and informational purposes only. Nothing contained here should be construed by anyone as an invitation or solicitation to buy or sell any security. This site does not contain personalized legal, tax, investment, or financial advice. Users of this site should consult with a qualified adviser to obtain advice suited to their personal circumstances.